US FDA approves Asahi Kasei's drug for persistent herpes infections

The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus ​sores in certain patients with weakened immune systems ‌who have not responded to available antiviral trea...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。